Strategic and tactical insights on pharmaceutical market access topics spanning distribution, pharmacy, and access and affordability.
Categories
DTC/DTP + Telemedicine – The Next Big Thing in Pharma?
The May 2025 Executive Order marks a seismic shift in the U.S. pharmaceutical patient access market.
Evolving Pharma: How DTC/DTP and Telemedicine are Redefining the Industry’s Future
By understanding DTC, DTP and the intersection with telemedicine, pharma can deliver more value to patients and drive measurable results.
Significant Changes in Healthcare: Regulations in Law
The pharmaceutical industry is facing a wave of regulatory changes in 2025 that will have a significant impact on stakeholders.
From Roadblocks to Runways: Aligning Services for a Smooth Patient Journey
Proven strategies for mapping and optimizing the patient journey, from diagnosis to ongoing care.
The Rise of Digital Health and Technology Integration in the Pharmaceutical Industry
In 2025, digital health is no longer a future consideration—it is a present imperative for key industry players in the pharmaceutical services sector, including manufacturers, specialty pharmacies, payers, and providers
Direct-to-Consumer (DTC) Changes Under the New Executive Order: What You Need to Know
As the US administration urges leading pharmaceutical manufacturers to implement MFN prescription drug pricing solutions, innovative approaches like DTC distribution for prescription medications are gaining increased attention.
Navigating the Complex World of Pharmaceutical Returns Processing
Efficiently managing product returns is a critical lever for controlling costs, minimizing operational inefficiencies, and reducing end-to-end complexity.
What Happens in Vegas… Ends Up in Our Blog: Asembia 2025 Edition
Asembia 2025 clarified that the pharma landscape is rapidly evolving, with innovation and partnership as the driving forces.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|
|